Subscribe To
novartis no longer expects earnings decline at under-review sandoz unit
Swiss drugmaker novartis said earnings at its Sandoz unit, the maker of cheap generic drugs that might ...
July 19, 2022, 1:20 am
novartis debuted its first integrated sustainability and finance report this year — more companies are likely to follow suit
The global pharmaceutical company, novartis, released its first-ever integrated social impact report. T...
July 6, 2022, 3:09 pm
novartis: a safe bear market value buy now yielding 4%
novartis is a leading global pharmaceutical company with a solid portfolio of drugs, a strong pipeline,...
July 6, 2022, 8:15 am
novartis is awakening from lethargy
The street consensus anticipates 7.71% net profit CAGR over the next 5 years. Targeted acquisition, a likely spinoff of Sandoz and $15B share buyback ...
July 6, 2022, 6:04 am
novartis will cut up to 8,000 jobs under ceo's shake-up plan
The pharmaceutical giant said about 1,400 roles in its Switzerland headquarters could be eliminated due to a restructuring plan....
June 28, 2022, 3:39 pm
Precision biosciences' (dtil) stock up this week: here's why
Shares of Precision BioSciences (DTIL) are up as the company inks a gene-editing deal with novartis to ...
June 23, 2022, 1:54 pm
novartis' (nvs) oncology drugs get approval for label expansion
novartis (NVS) obtains regulatory approval for label expansion of Tafinlar + Mekinist and Tabrecta....
June 23, 2022, 1:54 pm
Why precision biosciences shares are surging today
Precision BioSciences Inc (NASDAQ: DTIL) has entered into an exclusive worldwide in vivo gene editing research and development collaboration and lic...
June 22, 2022, 8:31 am
Astrazeneca weighing bid for mereo biopharma: report
AstraZeneca AZN, +0.48% AZN, +0.42% is considering a bid for London-based, U.S.-listed biotech Mereo BioPharma MREO, +16.03% , The Times reported with...
June 17, 2022, 3:44 am
novartis (nvs) wins fda nod for label expansion of kymriah
novartis' (NVS) CAR-T cell therapy Kymriah (tisagenlecleucel) gets an FDA approval for a third indicati...
May 30, 2022, 4:33 pm
Surface oncology: neither novartis, nor gsk or arkg is able to stop the decline
Surface Oncology has been a major drag for investors. There's no bad news, but there's no good news either....
May 25, 2022, 8:50 am
novartis is looking for deals. are these 3 biotechs on its list?
CEO Vas Narasimhan is seeking acquisitions under $2 billion....
May 2, 2022, 10:45 am
Why molecular partners shares are falling
Molecular Partners AG (NASDAQ: MOLN) shares are trading lower again Thursday on continued weakness after the company recently said its partner ...
April 28, 2022, 11:12 am
Why molecular partners shares are getting hammered
Molecular Partners AG (NASDAQ: MOLN) shares are trading lower by 36.52% at $8.38 after the company and its partner ...
April 27, 2022, 11:22 am
Molecular partners, novartis note eua for covid-19 therapy may need additional data
Molecular Partners AG (NASDAQ: MOLN) has provided an update regarding the Emergency Use Application (EUA) for ensovibep, a DARPin antiviral therape...
April 27, 2022, 6:03 am
novartis earnings get boost from sales of key drugs
Sales of heart failure treatment Entresto rise 39% in the first quarter....
April 26, 2022, 4:36 am
novartis posts higher net profit of $2.22 billion on sales of $12.53 billion
novartis on Tuesday posted rising earnings and sales for the first quarter of the year as its key drugs...
April 26, 2022, 1:39 am
novartis earnings edge higher on cosentyx, entresto
Core operating income at novartis edged 3% higher in the first quarter as sales growth from new drugs w...
April 26, 2022, 1:29 am
Here's 1 high-yield dividend stock to consider buying
Big pharma company novartis pays big dividends -- but there are other reasons for investors to buy its ...
April 25, 2022, 6:31 am
novartis to cut thousands of jobs in global revamp - paper
Swiss drugmaker novartis will cut thousands of jobs worldwide as it combines its pharma and oncology bu...
April 12, 2022, 3:19 am